Free Trial

MarketBeat Instant News Alerts

Essential Properties Realty Trust logo with Real Estate background

Essential Properties Realty Trust (NYSE:EPRT) Given New $32.00 Price Target at Wells Fargo & Company

Wells Fargo & Company increased their price target on shares of Essential Properties Realty Trust from $30.00 to $32.00 and gave the stock an "overweight" rating in a research report on Monday.

NYSE:EPRT
Read Essential Properties Realty Trust (NYSE:EPRT) Given New $32.00 Price Target at Wells Fargo & Company
EPR Properties logo with Real Estate background

EPR Properties (NYSE:EPR) Stock Gets Price Target Boost from Wells Fargo & Company

Wells Fargo & Company increased their price target on shares of EPR Properties from $56.00 to $62.00 and gave the company an "equal weight" rating in a research note on Monday.

NYSE:EPR
Read EPR Properties (NYSE:EPR) Stock Gets Price Target Boost from Wells Fargo & Company
Agree Realty logo with Real Estate background

Agree Realty (NYSE:ADC) Price Target Raised to $81.00

Wells Fargo & Company lifted their price objective on shares of Agree Realty from $79.00 to $81.00 and gave the stock an "overweight" rating in a research report on Monday.

NYSE:ADC
Read Agree Realty (NYSE:ADC) Price Target Raised to $81.00
Welltower logo with Real Estate background

Welltower (NYSE:WELL) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Wells Fargo & Company increased their price target on Welltower from $268.00 to $283.00 and gave the stock an "overweight" rating in a research report on Monday.

NYSE:WELL
Read Welltower (NYSE:WELL) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
VersaBank logo with Finance background

VersaBank (NASDAQ:VBNK) Earns Buy Rating from Roth Capital

Roth Capital reiterated a "buy" rating and issued a $32.00 target price (up from $28.00) on shares of VersaBank in a research note on Monday.

NASDAQ:VBNK
Read VersaBank (NASDAQ:VBNK) Earns Buy Rating from Roth Capital
Ventas logo with Real Estate background

Ventas (NYSE:VTR) Given New $102.00 Price Target at Wells Fargo & Company

Wells Fargo & Company upped their target price on shares of Ventas from $96.00 to $102.00 and gave the company an "overweight" rating in a report on Monday.

NYSE:VTR
Read Ventas (NYSE:VTR) Given New $102.00 Price Target at Wells Fargo & Company

Trending News

All MarketBeat Instant News Alerts

Hasbro logo with Consumer Discretionary background

Hasbro's (HAS) "Buy" Rating Reaffirmed at Roth Capital

NASDAQ:HAS
Read Hasbro's (HAS) "Buy" Rating Reaffirmed at Roth Capital
Sabra Healthcare REIT logo with Real Estate background

Sabra Healthcare REIT (NASDAQ:SBRA) Stock Gets Price Target Increase from Wells Fargo & Company

NASDAQ:SBRA
Read Sabra Healthcare REIT (NASDAQ:SBRA) Stock Gets Price Target Increase from Wells Fargo & Company
BP logo with Energy background

BP (NYSE:BP) Stock Gets Price Target Bump from Argus

NYSE:BP
Read BP (NYSE:BP) Stock Gets Price Target Bump from Argus
Omega Healthcare Investors logo with Real Estate background

Omega Healthcare Investors (NYSE:OHI) Stock Gets Price Target Boost from Wells Fargo & Company

NYSE:OHI
Read Omega Healthcare Investors (NYSE:OHI) Stock Gets Price Target Boost from Wells Fargo & Company
National Health Investors logo with Real Estate background

National Health Investors (NYSE:NHI) Stock Price Target Lowered at Wells Fargo & Company

NYSE:NHI
Read National Health Investors (NYSE:NHI) Stock Price Target Lowered at Wells Fargo & Company
Janus Living logo with Real Estate background

Janus Living (NYSE:JAN) Price Target Raised to $36.00

NYSE:JAN
Read Janus Living (NYSE:JAN) Price Target Raised to $36.00
Healthpeak Properties logo with Real Estate background

Healthpeak Properties (NYSE:DOC) Stock Price Target Raised at Wells Fargo & Company

NYSE:DOC
Read Healthpeak Properties (NYSE:DOC) Stock Price Target Raised at Wells Fargo & Company
Absci logo with Healthcare background

Guggenheim Has Lowered Expectations for Absci (NASDAQ:ABSI) Stock Price

NASDAQ:ABSI
Read Guggenheim Has Lowered Expectations for Absci (NASDAQ:ABSI) Stock Price
Healthcare Realty Trust logo with Real Estate background

Healthcare Realty Trust (NYSE:HR) Stock Gets Price Target Boost from Wells Fargo & Company

NYSE:HR
Read Healthcare Realty Trust (NYSE:HR) Stock Gets Price Target Boost from Wells Fargo & Company
Roivant Sciences logo with Healthcare background

Roivant Sciences (NASDAQ:ROIV) Stock Gets Price Target Increase from Guggenheim

NASDAQ:ROIV
Read Roivant Sciences (NASDAQ:ROIV) Stock Gets Price Target Increase from Guggenheim
CareTrust REIT logo with Real Estate background

CareTrust REIT (NYSE:CTRE) Given New $44.00 Price Target at Wells Fargo & Company

NYSE:CTRE
Read CareTrust REIT (NYSE:CTRE) Given New $44.00 Price Target at Wells Fargo & Company
3M logo with Industrials background

3M (NYSE:MMM) Stock Price Target Raised at Wells Fargo & Company

NYSE:MMM
Read 3M (NYSE:MMM) Stock Price Target Raised at Wells Fargo & Company
Axsome Therapeutics logo with Healthcare background

Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launch

NASDAQ:AXSM
Read Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launch
H World Group logo with Consumer Discretionary background

What H World Group (HTHT) Said on Its Q3 Earnings Call

NASDAQ:HTHT
Read What H World Group (HTHT) Said on Its Q3 Earnings Call
MasTec logo with Industrials background

MasTec (NYSE:MTZ) Price Target Cut to $335.00 by Analysts at Guggenheim

NYSE:MTZ
Read MasTec (NYSE:MTZ) Price Target Cut to $335.00 by Analysts at Guggenheim
ArriVent BioPharma logo with Healthcare background

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at Guggenheim

NASDAQ:AVBP
Read ArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at Guggenheim
Jade Biosciences logo with Healthcare background

Jade Biosciences (NASDAQ:JBIO) Stock Price Target Lowered at Guggenheim

NASDAQ:JBIO
Read Jade Biosciences (NASDAQ:JBIO) Stock Price Target Lowered at Guggenheim
Praxis Precision Medicines logo with Healthcare background

Guggenheim Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price

NASDAQ:PRAX
Read Guggenheim Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price
Zevra Therapeutics logo with Healthcare background

Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price

NASDAQ:ZVRA
Read Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock
Dynex Capital logo with Finance background

Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock

NYSE:DX
Read Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock
Csquare logo with background

Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock

NYSE:CSQR
Read Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock

Featured Articles and Offers

Alert Categories

All Alerts